Clinical Trial: Alzheimer's Disease Research Center (ADRC) PET Component Study

U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758660) titled 'Alzheimer's Disease Research Center (ADRC) PET Component Study' on Aug. 06.

Brief Summary: The purpose of this study is to further engage and characterize Alzheimer's Disease Research Center (ADRC) participants through additional research opportunities, particularly PET imaging. Amyloid and Tau PET imaging will be collected in 24 participants per year, for a total of 120 participants over five years.

All participants will be followed longitudinally, including through potential transitions from normal aging to mild cognitive impairment (MCI) and Alzheimer's disease and related dementias (ADRD).

Study Start Date: Aug. 06

Study Type...